nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—ALDH2—esophageal cancer	0.812	1	CbGaD
Nitroglycerin—Skin reaction—Capecitabine—esophageal cancer	0.00899	0.154	CcSEcCtD
Nitroglycerin—Localised skin reaction—Capecitabine—esophageal cancer	0.00899	0.154	CcSEcCtD
Nitroglycerin—ALDH2—Ethanol oxidation—ADH7—esophageal cancer	0.0073	0.0885	CbGpPWpGaD
Nitroglycerin—ALDH2—Ethanol oxidation—ADH1B—esophageal cancer	0.0064	0.0776	CbGpPWpGaD
Nitroglycerin—ALDH2—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00501	0.0608	CbGpPWpGaD
Nitroglycerin—ALDH2—exocrine gland—esophageal cancer	0.00497	0.104	CbGeAlD
Nitroglycerin—ALDH2—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00441	0.0534	CbGpPWpGaD
Nitroglycerin—ALDH2—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00439	0.0533	CbGpPWpGaD
Nitroglycerin—ALDH2—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00291	0.0353	CbGpPWpGaD
Nitroglycerin—GUCY1A2—lung—esophageal cancer	0.00259	0.054	CbGeAlD
Nitroglycerin—GUCY1A3—bronchus—esophageal cancer	0.00253	0.0527	CbGeAlD
Nitroglycerin—GUCY1B3—bronchus—esophageal cancer	0.00251	0.0523	CbGeAlD
Nitroglycerin—NPR1—epithelium—esophageal cancer	0.00238	0.0497	CbGeAlD
Nitroglycerin—NPR1—bronchus—esophageal cancer	0.00235	0.049	CbGeAlD
Nitroglycerin—NPR1—smooth muscle tissue—esophageal cancer	0.0023	0.0479	CbGeAlD
Nitroglycerin—GUCY1A3—trachea—esophageal cancer	0.00227	0.0473	CbGeAlD
Nitroglycerin—GUCY1B3—trachea—esophageal cancer	0.00225	0.047	CbGeAlD
Nitroglycerin—Angina unstable—Capecitabine—esophageal cancer	0.00214	0.0368	CcSEcCtD
Nitroglycerin—Diarrhoea haemorrhagic—Capecitabine—esophageal cancer	0.00214	0.0368	CcSEcCtD
Nitroglycerin—ALDH2—bronchus—esophageal cancer	0.00213	0.0444	CbGeAlD
Nitroglycerin—NPR1—trachea—esophageal cancer	0.00211	0.044	CbGeAlD
Nitroglycerin—ALDH2—smooth muscle tissue—esophageal cancer	0.00208	0.0435	CbGeAlD
Nitroglycerin—Hypoxemia—Methotrexate—esophageal cancer	0.00201	0.0345	CcSEcCtD
Nitroglycerin—ALDH2—trachea—esophageal cancer	0.00191	0.0399	CbGeAlD
Nitroglycerin—NPR1—digestive system—esophageal cancer	0.00181	0.0378	CbGeAlD
Nitroglycerin—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.00181	0.0219	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.00181	0.0219	CbGpPWpGaD
Nitroglycerin—GUCY1A2—lymph node—esophageal cancer	0.00177	0.0369	CbGeAlD
Nitroglycerin—ALDH2—digestive system—esophageal cancer	0.00165	0.0343	CbGeAlD
Nitroglycerin—GUCY1A3—lung—esophageal cancer	0.00163	0.034	CbGeAlD
Nitroglycerin—GUCY1B3—Platelet homeostasis—GNG7—esophageal cancer	0.00162	0.0196	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—GNG7—esophageal cancer	0.00162	0.0196	CbGpPWpGaD
Nitroglycerin—GUCY1B3—lung—esophageal cancer	0.00162	0.0338	CbGeAlD
Nitroglycerin—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.00161	0.0196	CbGpPWpGaD
Nitroglycerin—NPR1—lung—esophageal cancer	0.00151	0.0316	CbGeAlD
Nitroglycerin—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00146	0.0176	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00146	0.0176	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—GNG7—esophageal cancer	0.00144	0.0175	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00141	0.0171	CbGpPWpGaD
Nitroglycerin—ALDH2—lung—esophageal cancer	0.00137	0.0287	CbGeAlD
Nitroglycerin—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.0013	0.0157	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00124	0.015	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00115	0.0139	CbGpPWpGaD
Nitroglycerin—GUCY1A3—lymph node—esophageal cancer	0.00112	0.0233	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—esophageal cancer	0.00111	0.0231	CbGeAlD
Nitroglycerin—NPR1—lymph node—esophageal cancer	0.00104	0.0216	CbGeAlD
Nitroglycerin—ALDH2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00101	0.0122	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GSTO1—esophageal cancer	0.000958	0.0116	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000948	0.0115	CbGpPWpGaD
Nitroglycerin—ALDH2—lymph node—esophageal cancer	0.00094	0.0196	CbGeAlD
Nitroglycerin—GUCY1A2—Hemostasis—CAPZA1—esophageal cancer	0.000919	0.0111	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CAPZA1—esophageal cancer	0.000919	0.0111	CbGpPWpGaD
Nitroglycerin—Infection—Carboplatin—esophageal cancer	0.000888	0.0152	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PDE4D—esophageal cancer	0.000876	0.0106	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GNG7—esophageal cancer	0.000833	0.0101	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—SFN—esophageal cancer	0.000827	0.01	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00082	0.00994	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CAPZA1—esophageal cancer	0.000819	0.00993	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000777	0.00942	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ACTB—esophageal cancer	0.000752	0.00911	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—ADH7—esophageal cancer	0.00075	0.00909	CbGpPWpGaD
Nitroglycerin—Body temperature increased—Carboplatin—esophageal cancer	0.000707	0.0121	CcSEcCtD
Nitroglycerin—GUCY1B3—Platelet homeostasis—NOS2—esophageal cancer	0.000705	0.00855	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—NOS2—esophageal cancer	0.000705	0.00855	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000661	0.00801	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—ADH1B—esophageal cancer	0.000657	0.00797	CbGpPWpGaD
Nitroglycerin—Hypoxia—Methotrexate—esophageal cancer	0.000635	0.0109	CcSEcCtD
Nitroglycerin—GUCY1A3—Platelet homeostasis—NOS2—esophageal cancer	0.000628	0.00762	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000621	0.00753	CbGpPWpGaD
Nitroglycerin—Chest discomfort—Capecitabine—esophageal cancer	0.000612	0.0105	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP26A1—esophageal cancer	0.000611	0.00741	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ATP1B2—esophageal cancer	0.000609	0.00738	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ATP1B2—esophageal cancer	0.000609	0.00738	CbGpPWpGaD
Nitroglycerin—Paralysis—Methotrexate—esophageal cancer	0.000581	0.00995	CcSEcCtD
Nitroglycerin—Burning sensation—Methotrexate—esophageal cancer	0.000581	0.00995	CcSEcCtD
Nitroglycerin—Renal failure acute—Cisplatin—esophageal cancer	0.000578	0.00991	CcSEcCtD
Nitroglycerin—Cyanosis—Methotrexate—esophageal cancer	0.00057	0.00977	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—GSTO1—esophageal cancer	0.000568	0.00689	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—NOS3—esophageal cancer	0.000567	0.00687	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—NOS3—esophageal cancer	0.000567	0.00687	CbGpPWpGaD
Nitroglycerin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000551	0.00945	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—DOCK2—esophageal cancer	0.00055	0.00667	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—DOCK2—esophageal cancer	0.00055	0.00667	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ATP1B2—esophageal cancer	0.000543	0.00658	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—NOS3—esophageal cancer	0.000505	0.00613	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—DOCK2—esophageal cancer	0.000491	0.00595	CbGpPWpGaD
Nitroglycerin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000487	0.00836	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—PFN1—esophageal cancer	0.000475	0.00576	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PFN1—esophageal cancer	0.000475	0.00576	CbGpPWpGaD
Nitroglycerin—Sweating increased—Cisplatin—esophageal cancer	0.000449	0.0077	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—GSTT1—esophageal cancer	0.00044	0.00534	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000438	0.00531	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2A6—esophageal cancer	0.000435	0.00528	CbGpPWpGaD
Nitroglycerin—Renal failure acute—Capecitabine—esophageal cancer	0.000426	0.0073	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PFN1—esophageal cancer	0.000424	0.00513	CbGpPWpGaD
Nitroglycerin—Hot flush—Capecitabine—esophageal cancer	0.00042	0.00721	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000417	0.00715	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Capecitabine—esophageal cancer	0.000417	0.00715	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—PTGS1—esophageal cancer	0.000413	0.005	CbGpPWpGaD
Nitroglycerin—Stomatitis—Cisplatin—esophageal cancer	0.000401	0.00687	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—CFL1—esophageal cancer	0.000385	0.00467	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CFL1—esophageal cancer	0.000385	0.00467	CbGpPWpGaD
Nitroglycerin—Bradycardia—Cisplatin—esophageal cancer	0.000376	0.00644	CcSEcCtD
Nitroglycerin—Coma—Methotrexate—esophageal cancer	0.000369	0.00632	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—GNG7—esophageal cancer	0.000363	0.0044	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GNG7—esophageal cancer	0.000363	0.0044	CbGpPWpGaD
Nitroglycerin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000359	0.00616	CcSEcCtD
Nitroglycerin—Visual impairment—Cisplatin—esophageal cancer	0.000356	0.0061	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP1B1—esophageal cancer	0.000351	0.00425	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CFL1—esophageal cancer	0.000343	0.00416	CbGpPWpGaD
Nitroglycerin—Cardiac disorder—Cisplatin—esophageal cancer	0.000343	0.00587	CcSEcCtD
Nitroglycerin—Flushing—Cisplatin—esophageal cancer	0.000343	0.00587	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—GNG7—esophageal cancer	0.000336	0.00407	CbGpPWpGaD
Nitroglycerin—Immune system disorder—Cisplatin—esophageal cancer	0.000333	0.00572	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000333	0.0057	CcSEcCtD
Nitroglycerin—Angina pectoris—Capecitabine—esophageal cancer	0.000331	0.00568	CcSEcCtD
Nitroglycerin—Sweating increased—Capecitabine—esophageal cancer	0.000331	0.00568	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP19A1—esophageal cancer	0.00033	0.004	CbGpPWpGaD
Nitroglycerin—Arrhythmia—Cisplatin—esophageal cancer	0.00033	0.00565	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—GNG7—esophageal cancer	0.000323	0.00392	CbGpPWpGaD
Nitroglycerin—Erythema—Cisplatin—esophageal cancer	0.000321	0.00551	CcSEcCtD
Nitroglycerin—Renal failure acute—Methotrexate—esophageal cancer	0.000317	0.00544	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00031	0.00532	CcSEcCtD
Nitroglycerin—Visual disturbance—Methotrexate—esophageal cancer	0.000309	0.0053	CcSEcCtD
Nitroglycerin—Infestation NOS—Capecitabine—esophageal cancer	0.000303	0.0052	CcSEcCtD
Nitroglycerin—Infestation—Capecitabine—esophageal cancer	0.000303	0.0052	CcSEcCtD
Nitroglycerin—Vision blurred—Cisplatin—esophageal cancer	0.000303	0.00519	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000303	0.00519	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—HSPA5—esophageal cancer	0.000296	0.00359	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—HSPA5—esophageal cancer	0.000296	0.00359	CbGpPWpGaD
Nitroglycerin—Stomatitis—Capecitabine—esophageal cancer	0.000295	0.00507	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NOS3—esophageal cancer	0.000292	0.00354	CbGpPWpGaD
Nitroglycerin—Bradycardia—Capecitabine—esophageal cancer	0.000277	0.00475	CcSEcCtD
Nitroglycerin—Rhinitis—Capecitabine—esophageal cancer	0.000273	0.00468	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000272	0.00466	CcSEcCtD
Nitroglycerin—Pharyngitis—Capecitabine—esophageal cancer	0.00027	0.00463	CcSEcCtD
Nitroglycerin—Oedema peripheral—Capecitabine—esophageal cancer	0.000268	0.0046	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—HSPA5—esophageal cancer	0.000264	0.0032	CbGpPWpGaD
Nitroglycerin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000262	0.0045	CcSEcCtD
Nitroglycerin—Visual impairment—Capecitabine—esophageal cancer	0.000262	0.0045	CcSEcCtD
Nitroglycerin—Infection—Cisplatin—esophageal cancer	0.000261	0.00447	CcSEcCtD
Nitroglycerin—Nervous system disorder—Cisplatin—esophageal cancer	0.000257	0.00441	CcSEcCtD
Nitroglycerin—Tachycardia—Cisplatin—esophageal cancer	0.000256	0.00439	CcSEcCtD
Nitroglycerin—Skin disorder—Cisplatin—esophageal cancer	0.000255	0.00437	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000254	0.00435	CcSEcCtD
Nitroglycerin—Cardiac disorder—Capecitabine—esophageal cancer	0.000253	0.00433	CcSEcCtD
Nitroglycerin—Flushing—Capecitabine—esophageal cancer	0.000253	0.00433	CcSEcCtD
Nitroglycerin—Angiopathy—Capecitabine—esophageal cancer	0.000247	0.00423	CcSEcCtD
Nitroglycerin—Immune system disorder—Capecitabine—esophageal cancer	0.000246	0.00421	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000245	0.0042	CcSEcCtD
Nitroglycerin—Hypotension—Cisplatin—esophageal cancer	0.000245	0.0042	CcSEcCtD
Nitroglycerin—Arrhythmia—Capecitabine—esophageal cancer	0.000243	0.00417	CcSEcCtD
Nitroglycerin—Mental disorder—Capecitabine—esophageal cancer	0.000238	0.00409	CcSEcCtD
Nitroglycerin—Erythema—Capecitabine—esophageal cancer	0.000237	0.00406	CcSEcCtD
Nitroglycerin—Paraesthesia—Cisplatin—esophageal cancer	0.000235	0.00404	CcSEcCtD
Nitroglycerin—Dyspnoea—Cisplatin—esophageal cancer	0.000234	0.00401	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000226	0.00388	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—esophageal cancer	0.000226	0.00387	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—esophageal cancer	0.000226	0.00387	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—esophageal cancer	0.000226	0.00387	CcSEcCtD
Nitroglycerin—Vision blurred—Capecitabine—esophageal cancer	0.000223	0.00383	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—esophageal cancer	0.00022	0.00377	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—ABL1—esophageal cancer	0.000219	0.00266	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ABL1—esophageal cancer	0.000219	0.00266	CbGpPWpGaD
Nitroglycerin—Sweating—Methotrexate—esophageal cancer	0.000216	0.00371	CcSEcCtD
Nitroglycerin—Feeling abnormal—Cisplatin—esophageal cancer	0.000216	0.00371	CcSEcCtD
Nitroglycerin—Vertigo—Capecitabine—esophageal cancer	0.000213	0.00365	CcSEcCtD
Nitroglycerin—Syncope—Capecitabine—esophageal cancer	0.000212	0.00364	CcSEcCtD
Nitroglycerin—Palpitations—Capecitabine—esophageal cancer	0.000209	0.00359	CcSEcCtD
Nitroglycerin—Loss of consciousness—Capecitabine—esophageal cancer	0.000208	0.00357	CcSEcCtD
Nitroglycerin—Body temperature increased—Cisplatin—esophageal cancer	0.000207	0.00355	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—esophageal cancer	0.000201	0.00345	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0002	0.00343	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—ABL1—esophageal cancer	0.000195	0.00237	CbGpPWpGaD
Nitroglycerin—Visual impairment—Methotrexate—esophageal cancer	0.000195	0.00335	CcSEcCtD
Nitroglycerin—Confusional state—Capecitabine—esophageal cancer	0.000195	0.00334	CcSEcCtD
Nitroglycerin—Hypersensitivity—Cisplatin—esophageal cancer	0.000193	0.00331	CcSEcCtD
Nitroglycerin—Infection—Capecitabine—esophageal cancer	0.000192	0.00329	CcSEcCtD
Nitroglycerin—Shock—Capecitabine—esophageal cancer	0.00019	0.00326	CcSEcCtD
Nitroglycerin—Nervous system disorder—Capecitabine—esophageal cancer	0.00019	0.00325	CcSEcCtD
Nitroglycerin—Tachycardia—Capecitabine—esophageal cancer	0.000189	0.00324	CcSEcCtD
Nitroglycerin—Asthenia—Cisplatin—esophageal cancer	0.000188	0.00323	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—esophageal cancer	0.000188	0.00322	CcSEcCtD
Nitroglycerin—Skin disorder—Capecitabine—esophageal cancer	0.000188	0.00322	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000187	0.0032	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—esophageal cancer	0.000184	0.00315	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—esophageal cancer	0.000183	0.00314	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000183	0.00313	CcSEcCtD
Nitroglycerin—Hypotension—Capecitabine—esophageal cancer	0.000181	0.0031	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—esophageal cancer	0.000177	0.00304	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC52A3—esophageal cancer	0.000177	0.00215	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—BLVRB—esophageal cancer	0.000177	0.00215	CbGpPWpGaD
Nitroglycerin—Erythema—Methotrexate—esophageal cancer	0.000176	0.00302	CcSEcCtD
Nitroglycerin—Paraesthesia—Capecitabine—esophageal cancer	0.000174	0.00298	CcSEcCtD
Nitroglycerin—Dyspnoea—Capecitabine—esophageal cancer	0.000172	0.00296	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000167	0.00286	CcSEcCtD
Nitroglycerin—Vomiting—Cisplatin—esophageal cancer	0.000167	0.00286	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—esophageal cancer	0.000166	0.00285	CcSEcCtD
Nitroglycerin—Rash—Cisplatin—esophageal cancer	0.000165	0.00284	CcSEcCtD
Nitroglycerin—Dermatitis—Cisplatin—esophageal cancer	0.000165	0.00283	CcSEcCtD
Nitroglycerin—Feeling abnormal—Capecitabine—esophageal cancer	0.000159	0.00273	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—esophageal cancer	0.000158	0.00272	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000158	0.00271	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—NOS2—esophageal cancer	0.000158	0.00192	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—NOS2—esophageal cancer	0.000158	0.00192	CbGpPWpGaD
Nitroglycerin—Nausea—Cisplatin—esophageal cancer	0.000156	0.00267	CcSEcCtD
Nitroglycerin—Urticaria—Capecitabine—esophageal cancer	0.000154	0.00263	CcSEcCtD
Nitroglycerin—Abdominal pain—Capecitabine—esophageal cancer	0.000153	0.00262	CcSEcCtD
Nitroglycerin—Body temperature increased—Capecitabine—esophageal cancer	0.000153	0.00262	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC10A2—esophageal cancer	0.000151	0.00183	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CA1—esophageal cancer	0.000151	0.00183	CbGpPWpGaD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000149	0.00256	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—esophageal cancer	0.000145	0.00249	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000144	0.00247	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—esophageal cancer	0.000143	0.00245	CcSEcCtD
Nitroglycerin—Hypersensitivity—Capecitabine—esophageal cancer	0.000142	0.00244	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—CREBBP—esophageal cancer	0.000142	0.00172	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CREBBP—esophageal cancer	0.000142	0.00172	CbGpPWpGaD
Nitroglycerin—Nervous system disorder—Methotrexate—esophageal cancer	0.000141	0.00242	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—NOS2—esophageal cancer	0.000141	0.00171	CbGpPWpGaD
Nitroglycerin—Skin disorder—Methotrexate—esophageal cancer	0.00014	0.0024	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000139	0.00239	CcSEcCtD
Nitroglycerin—Asthenia—Capecitabine—esophageal cancer	0.000139	0.00238	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CA2—esophageal cancer	0.000138	0.00167	CbGpPWpGaD
Nitroglycerin—Pruritus—Capecitabine—esophageal cancer	0.000137	0.00235	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—esophageal cancer	0.000134	0.00231	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—esophageal cancer	0.000129	0.00222	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—esophageal cancer	0.000128	0.0022	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PLCE1—esophageal cancer	0.000128	0.00155	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADH7—esophageal cancer	0.000128	0.00155	CbGpPWpGaD
Nitroglycerin—Somnolence—Methotrexate—esophageal cancer	0.000128	0.00219	CcSEcCtD
Nitroglycerin—Dizziness—Capecitabine—esophageal cancer	0.000128	0.00219	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—NOS3—esophageal cancer	0.000127	0.00154	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NOS3—esophageal cancer	0.000127	0.00154	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CREBBP—esophageal cancer	0.000126	0.00153	CbGpPWpGaD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000124	0.00213	CcSEcCtD
Nitroglycerin—Vomiting—Capecitabine—esophageal cancer	0.000123	0.00211	CcSEcCtD
Nitroglycerin—Rash—Capecitabine—esophageal cancer	0.000122	0.00209	CcSEcCtD
Nitroglycerin—Dermatitis—Capecitabine—esophageal cancer	0.000122	0.00209	CcSEcCtD
Nitroglycerin—Headache—Capecitabine—esophageal cancer	0.000121	0.00208	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—esophageal cancer	0.000119	0.00203	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000118	0.00202	CcSEcCtD
Nitroglycerin—Nausea—Capecitabine—esophageal cancer	0.000115	0.00197	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—esophageal cancer	0.000114	0.00196	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—esophageal cancer	0.000114	0.00195	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—esophageal cancer	0.000114	0.00195	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—NOS3—esophageal cancer	0.000113	0.00137	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADH1B—esophageal cancer	0.000112	0.00136	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TYMP—esophageal cancer	0.000107	0.0013	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Methotrexate—esophageal cancer	0.000106	0.00182	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CYP26A1—esophageal cancer	0.000104	0.00127	CbGpPWpGaD
Nitroglycerin—Asthenia—Methotrexate—esophageal cancer	0.000103	0.00177	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ALOX15—esophageal cancer	0.000102	0.00123	CbGpPWpGaD
Nitroglycerin—Pruritus—Methotrexate—esophageal cancer	0.000102	0.00175	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—TPI1—esophageal cancer	9.71e-05	0.00118	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTO1—esophageal cancer	9.71e-05	0.00118	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—EP300—esophageal cancer	9.66e-05	0.00117	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—EP300—esophageal cancer	9.66e-05	0.00117	CbGpPWpGaD
Nitroglycerin—Dizziness—Methotrexate—esophageal cancer	9.52e-05	0.00163	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ALDOB—esophageal cancer	9.31e-05	0.00113	CbGpPWpGaD
Nitroglycerin—Vomiting—Methotrexate—esophageal cancer	9.15e-05	0.00157	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—esophageal cancer	9.07e-05	0.00156	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—esophageal cancer	9.07e-05	0.00155	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—esophageal cancer	9.02e-05	0.00155	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GAPDH—esophageal cancer	8.97e-05	0.00109	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CRABP1—esophageal cancer	8.88e-05	0.00108	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—EP300—esophageal cancer	8.61e-05	0.00104	CbGpPWpGaD
Nitroglycerin—Nausea—Methotrexate—esophageal cancer	8.55e-05	0.00147	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GNG7—esophageal cancer	8.45e-05	0.00102	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTT1—esophageal cancer	7.53e-05	0.000913	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2A6—esophageal cancer	7.45e-05	0.000903	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CA—esophageal cancer	7.15e-05	0.000866	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CA—esophageal cancer	7.15e-05	0.000866	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ENO1—esophageal cancer	7.06e-05	0.000856	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS1—esophageal cancer	7.06e-05	0.000856	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSME1—esophageal cancer	6.96e-05	0.000843	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSME2—esophageal cancer	6.96e-05	0.000843	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TP53—esophageal cancer	6.91e-05	0.000838	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TP53—esophageal cancer	6.91e-05	0.000838	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CA—esophageal cancer	6.37e-05	0.000772	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TP53—esophageal cancer	6.16e-05	0.000747	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP1B1—esophageal cancer	6e-05	0.000728	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP19A1—esophageal cancer	5.64e-05	0.000684	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HMOX1—esophageal cancer	5.15e-05	0.000624	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCB1—esophageal cancer	4.94e-05	0.000599	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CREBBP—esophageal cancer	3.3e-05	0.0004	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NOS3—esophageal cancer	2.96e-05	0.000359	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS2—esophageal cancer	2.7e-05	0.000328	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—EP300—esophageal cancer	2.25e-05	0.000273	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CA—esophageal cancer	1.66e-05	0.000202	CbGpPWpGaD
